http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2014000233-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6493e075b586cf5568b69116429349a8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca6cbe124b9622300e65deb1a307768b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b20f8e8eca57d97b786360ec6ffa54b6
publicationDate 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2014000233-A1
titleOfInvention Transdermal delivery system comprising buprenorphine
abstract The invention relates to transdermal therapeutic system for the transdermal administration of buprenorphine, comprising a buprenorphine-containing self- adhesive layer structure comprising A) a buprenophihine-impermeable backing layer, and B) a buprenorphine-containing pressure-sensitive adhesive layer on said buprenorphine-impermeable backing layer, the adhesive layer comprising a) at least one polymer-based pressure-sensitive adhesive, b) an analgesically effective amount of buprenorphine base or a pharmaceutically acceptable salt thereof, and c) a carboxylic acid selected from the group consisting of oleic acid, linoleic acid and linolenic acid, levulinic acid and mixtures thereof, in an amount sufficient so that said analgesically effective amount of buprenorphine is solubilized therein to form a mixture, and the carboxylic acid buprenorphine mixture forms dispersed deposits in the said pressure-sensitive adhesive, wherein said buprenorphine-containing pressure-sensitive adhesive layer is the skin contact layer.
priorityDate 2011-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409736587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408376618

Total number of triples: 31.